: Novo Nordisk, maker of Ozempic and Wegovy, to invest more than $6 billion to expand production
Read Time:3 Second
Drugmaker set to expand Danish facilities amid ongoing Wegovy shortage.
It’s rescued investors in the past from a lost decade
‘There’s this debate between a hard landing, a soft landing or no landing that continues,’ says Lerner at Truist Advisory...
Many 5% CDs are going away in the weeks after the Fed’s first interest-rate cut. Some have already disappeared.
Some analysts warn the pool of potential gold buyers could begin to run dry.
September has historically been the worst month for U.S. stocks — but not this year
Homeowners looking to leverage lower mortgage rates can ask their lenders for a “rate modification,” financial experts say.